Viewport width =

AuthorFinnius Teppett

Author Archive: Finnius Teppett

rss feed

February 28, 2016

Martin Shkreli rose to fame last year when, as CEO of drug company Turing Pharmaceuticals, he bought the rights to the drug Daraprim and jacked up the price by over 5000% overnight. When the news about Daraprim, a drug used to treat toxoplasmosis (a parasitic infection that can develop in young children and some cancer […]